Pyramid Pharma Services is a contract development and manufacturing organisation (CDMO) focused on parenteral drug products, providing aseptic manufacturing, development, and analytical services to pharmaceutical and biotechnology companies. Headquartered in Costa Mesa, California, the company was founded in 1988 and has built capabilities across the full drug product lifecycle, from preclinical development through to commercial supply and regulatory support.

The company supports a range of modalities, including biologics, peptides, and small molecules, with a particular emphasis on injectable therapies. Its integrated model is designed to provide a single point of access for clients, combining formulation, process development, manufacturing, and quality services. Pyramid Pharma Services positions itself as a partner across all stages of development, offering scalable solutions tailored to both emerging biotech firms and established pharmaceutical companies.

With more than three decades of experience, the company has expanded from its origins in analytical services into a full-service CDMO offering. Its expertise includes sterile fill-finish manufacturing, lyophilisation, and regulatory support, underpinned by quality systems aligned with global standards.

Key products and services

• Sterile fill-finish manufacturing (vials, syringes, and injectable formats)
• Drug product formulation and process development (liquid and lyophilised)
• Lyophilisation development and GMP manufacturing
• Clinical and commercial drug product manufacturing
• Analytical method development, validation, and quality control testing
• Stability studies under ICH conditions
• Quality assurance and regulatory support services
• Labeling, packaging, storage, and global distribution

Pyramid Pharma Services operates as a drug product CDMO with a focus on injectable therapies, offering integrated contract manufacturing and development services across the pharmaceutical value chain. Its capabilities in sterile manufacturing, combined with analytical and regulatory expertise, position the company to support partners from early-stage development through to commercial supply.